Which first? Surgery or biologic therapy for ileocolic Crohn’s disease in the real world
In our cohort, the risk of recurrent ileocolic Crohn's disease was similar whether patients were treated with a 'surgery first' or 'biologic first' approach.
Authors
- David Zocche (ORCID: https://orcid.org/0000-0003-1390-0334)
- Cas D. P. van’t Hullenaar (ORCID: https://orcid.org/0000-0002-2588-8830)
- Abhilashaben S. Patel
- Caroline D.M. Witjes
- Simon P.L. Travis (ORCID: https://orcid.org/0000-0002-2690-4361)
- Sarah Cripps (ORCID: https://orcid.org/0000-0002-5967-0178)
- Bruce George (ORCID: https://orcid.org/0000-0002-1522-5312)
Institutions
- University of Oxford (GB)
- IJsselland Ziekenhuis (NL)
- Oxford BioMedica (United Kingdom) (GB)
Publication Details
- Journal
- Expert Review of Gastroenterology & Hepatology
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1080/17474124.2025.2519167
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82